(Q46600597)

English

Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP. (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

1 reference

based on heuristic

inferred from title

4

object named as

Peter Hillmen

0 references

author name string

D Wayne Thomas

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Roger G Owen

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Stephen A N Johnson

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

John F Seymour

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Max M Wolf

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Simon A J Rule

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

publication date

1 April 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Leukemia & Lymphoma

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

46

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

549-552

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029841

21 January 2018

Identifiers

10.1080/10428190400029841

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16019483

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46600597&oldid=1561096220"